B Blue Nutraceuticals SA
B Blue Nutraceuticals reported total assets of 31,757 € at the end of the 2025 financial year (annual accounts filed with the NBB on 16 Sep 2026).
The score of B Blue Nutraceuticals shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity -98 % Total assets -46 %
Accounts of the company itself (not consolidated).
The full file covers 10 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
B Blue Nutraceuticals's annual accounts
Filed annual accounts
- Year ended 31 Dec 2025filed on 16 Sep 2026
- Year ended 31 Dec 2024filed on 30 Sep 2025
- Year ended 31 Dec 2023filed on 10 Feb 2025
- Year ended 31 Dec 2022filed on 23 Oct 2023
- Year ended 31 Dec 2021filed on 19 Sep 2022
B Blue Nutraceuticals's financial analysis
- Solvency3.6%sector median: 22.7%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of B Blue Nutraceuticals
B Blue Nutraceuticals's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0555.699.835
- VAT number
- BE0555699835
- Peppol
- Not found on Peppol as of 10 Nov 2026 · Check
- Legal form
- SA
- Incorporated
- 04 Jul 2014
- Registered office
- 4800 Verviers
- Latest accounts
- 2025 · filed on 16 Sep 2026
- Activity
- Manufacture of soft drinks and bottled waters (NACE 11070)
B Blue Nutraceuticals (SA) has been based in Verviers since 2014, active in: manufacture of soft drinks and bottled waters. For 2025, it reports a net loss of 9,336 € and equity of 1,157 €; its revenue is not published. Its solvency stands at 3.6%, below the median of its sector (22.7%).
Guide: Reading Belgian SME accounts: the five figures that count →
Companies similar to B Blue Nutraceuticals
Companies in the same business, of comparable size and area, outside its group.
- Cogniaux Berlemont Manufacture of soft drinks and bottled waters Anderlecht · balance sheet 61,538 €
- EZZ Manufacture of soft drinks and bottled waters Aalst · balance sheet 29,368 €
- Sipsnsoda Manufacture of soft drinks and bottled waters Hasselt · balance sheet 62,504 €
- JUZU Manufacture of soft drinks and bottled waters Arlon · balance sheet 69,987 €
- Greenleaf Retail sale of beverages Lokeren · balance sheet 46,296 €
- Grizzly Bob Manufacturing Manufacture of fruit and vegetable juice Seneffe · balance sheet 43,071 €
- Taste Group Manufacture of soft drinks and bottled waters Tervuren · balance sheet 18,438 €
- Puck Drinks Manufacture of soft drinks and bottled waters Kortrijk · balance sheet 92,761 €
Frequently asked questions about B Blue Nutraceuticals
What is the revenue of B Blue Nutraceuticals?
B Blue Nutraceuticals files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of B Blue Nutraceuticals?
In Belgium, the VAT number is the company number prefixed with BE: BE0555699835 for B Blue Nutraceuticals, if the company is VAT-registered. Its company number (CBE) is 0555.699.835.
Where is the registered office of B Blue Nutraceuticals?
According to the CBE register, the registered office of B Blue Nutraceuticals is in 4800 Verviers.
What is the equity of B Blue Nutraceuticals?
At the close of the 2025 financial year, the equity of B Blue Nutraceuticals amounts to 1,157 €, a solvency of 3.6% of total assets.
Who manages B Blue Nutraceuticals?
The register lists 3 active mandates at B Blue Nutraceuticals. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of B Blue Nutraceuticals
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →